Reinhard Horowski

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Schering Aktiengesellschaft, Neurobiotec Gmbh, Sinoxa Pharma Gmbh. Active years: 1977-2017.

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 84.6

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 235(Granted Patents)

Company Filing History:

11 out of 1,409

Schering Aktiengesellschaft

Years Active: 1977-2017

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9695173 - Pharmaceutical compositions for the treatment of capillary arteriopathy (2017-07-04),

2. 7258871 - Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states (2007-08-21),

3. 4970200 - Agent for treatment of Parkinson's disease (1990-11-13),

4. 4857298 - I*-diagnostics for monoamine receptors using ergolines (1989-08-15),

5. 4711891 - Use of terguride as a geriatric agent (1987-12-08),

6. 4522820 - Trans-dihydrolisuride antipsychotic (1985-06-11),

7. 4379790 - (Erolinyl)-N,N-diethylurea derivatives, and their preparation and use (1983-04-12),

8. 4193926 - 4-(Polyalkoxy phenyl)-2-pyrrolidones (1980-03-18),

9. 4080456 - Diacylapomorphines (1978-03-21),

10. 4045574 - D-Homo-20-ketopregnanes (1977-08-30),

11. 4029777 - 18-Methyl-19-nor-20-ketopregnanes and process for the preparation thereof (1977-06-14),

12. 4020164 - Benzomorphan derivatives (1977-04-26),

13. 4012495 - 4-(Polyalkoxyphenyl)-2-pyrrolidones (1977-03-15),

Title: Reinhard Horowski: Innovator in Pharmaceutical Compositions

Introduction

Reinhard Horowski is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of various medical conditions. With a total of 13 patents to his name, Horowski's work has had a considerable impact on medical science.

Latest Patents

Horowski's latest patents include innovative pharmaceutical compositions aimed at treating capillary arteriopathy. One of his key inventions involves the use of ergot derivatives or ergolines, specifically lisuride and terguride, for the prophylaxis and treatment of constrictive capillary arteriopathy. This condition encompasses diseases such as pulmonary arterial hypertension and secondary Raynaud's syndrome. Another significant patent focuses on a combination of a transdermal therapeutic system and oral or parenteral preparations containing dopamine agonists. This invention is designed for the treatment of dopaminergic disease states, utilizing a system that allows for continuous application of the therapeutic agent.

Career Highlights

Throughout his career, Reinhard Horowski has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Schering Aktiengesellschaft and Neurobiotec GmbH. His work in these organizations has contributed to the advancement of medical treatments and innovations.

Collaborations

Horowski has collaborated with esteemed colleagues, including Helmut Wachtel and Wolfgang Kehr. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in pharmaceutical research.

Conclusion

Reinhard Horowski's contributions to the field of pharmaceuticals are noteworthy, with a focus on innovative treatments for complex medical conditions. His patents reflect a commitment to improving patient care through scientific advancements.